| The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management MY Abou-Ismail, A Diamond, S Kapoor, Y Arafah, L Nayak Thrombosis research 194, 101-115, 2020 | 697 | 2020 |
| Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, ... JAMA oncology 7 (12), 1856-1861, 2021 | 95 | 2021 |
| Ibrutinib is associated with increased cardiovascular events and major bleeding in older CLL patients A Diamond, WP Bensken, L Vu, W Dong, SM Koroukian, P Caimi Cardio Oncology 5 (2), 233-243, 2023 | 5 | 2023 |
| Three Fold Risk of Atrial Fibrillation in Ibrutinib Treated CLL Patients without Increased Risk of Stroke: A SEER-Medicare Database Analysis A Diamond, WP Bensken, W Dong, SC Markt, SM Koroukian, P Caimi Blood 136, 18-19, 2020 | 5 | 2020 |
| Cardiovascular Toxicity after Therapy for Diffuse Large B Cell Lymphoma Occurs Early and Results in Decreased Overall Survival. SR Ayyappan, A Diamond, V Gupta, B Cooper, BK Tomlinson, E Malek, ... Blood 128 (22), 105, 2016 | 5 | 2016 |
| Corrigendum to “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management”[Thromb. Res., 194, October 2020, Pages 101–115] MY Abou-Ismail, A Diamond, S Kapoor, Y Arafah, L Nayak Thrombosis Research 204, 146, 2021 | 4 | 2021 |
| Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines A Diamond, S Ayyappan, S Cao, N Tashtish, K Boughan, B Cooper, PF Fu, ... Hematological oncology 40 (4), 626-636, 2022 | 3 | 2022 |
| Effect of vitamin K on coagulopathy of liver disease: a single center retrospective review BC Hambley, A Diamond, S Connie, S Partovi, T Smith, C LoPresti Blood 128 (22), 2583, 2016 | 3 | 2016 |
| Outcomes and characteristics of untreated diffuse large B-cell lymphoma (DLBCL) patients: a SEER-medicare database analysis A Diamond, WP Bensken, L Vu, SM Koroukian, PF Caimi Blood 140 (Supplement 1), 10979-10980, 2022 | 2 | 2022 |
| Development of a Risk Score for Cardiovascular Events in Anthracycline Treated DLBCL Patients A Diamond, S Ayyappan, S Cao, N Tashtish, KM Boughan, BW Cooper, ... Blood 138, 2536, 2021 | 2 | 2021 |
| Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates M Keenan, A Diamond, K Boughan, B Cooper, M Gallogly, E Malek, ... Clinical Lymphoma Myeloma and Leukemia 21 (11), 799-804, 2021 | 2 | 2021 |
| Venous thromboembolic events in diffuse large B cell lymphoma patients: risk factors and outcomes SR Ayyappan, V Gupta, A Diamond, B Cooper, BK Tomlinson, E Malek, ... Blood 128 (22), 3611, 2016 | 1 | 2016 |
| Safety and Efficacy Outcomes of Early Cessation of Anti-PD1 Therapy in Patients 80 Years or Older: A Retrospective Cohort Study K Fletcher, A Cortellini, T Ganta, R Kankaria, H Song, F Ye, R Irlmeier, ... Cancer Letters, 217001, 2024 | | 2024 |
| Clinical Outcomes of Patients with Newly Diagnosed Large B-Cell Lymphoma in a Safety-Net Hospital System JY Jiang, C Nze, D Guffey, R Kim, AO Oluyomi, O Rosales, R Bandyo, ... Blood Neoplasia, 100020, 2024 | | 2024 |
| From mutation to management: Advancing Langerhans cell histiocytosis treatment through combination therapies A Diamond British Journal of Haematology 204 (5), 1588-1589, 2024 | | 2024 |
| Clinical Outcomes in Patients with Lymphoma at a Safety-Net Hospital System C Nze, JY Jiang, D Guffey, R Kim, AO Oluyomi, O Rosales, R Bandyo, ... International Journal of Cancer Care and Delivery, 2024 | | 2024 |
| HSR24-130: Real-World Outcomes in Patients With Burkitt Lymphoma in a Safety-Net Health System M Lee, JY Jiang, C Nze, D Guffey, R Kim, AO Oluyomi, O Rosales, ... Journal of the National Comprehensive Cancer Network 22 (2.5), 2024 | | 2024 |
| Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System JY Jiang, C Nze, D Guffey, R Kim, AO Ouyomi, O Rosales, R Bandyo, ... Blood 142, 5140, 2023 | | 2023 |
| Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis A Diamond, L Vu, WP Bensken, SM Koroukian, PF Caimi Leukemia 37 (7), 1558-1560, 2023 | | 2023 |
| Diffuse Large B-Cell Lymphoma (DLBCL) Treatment Patterns and Outcomes in the Oldest-Old (≥ 85 years): A SEER-Medicare Database Analysis A Diamond, WP Bensken, L Vu, SM Koroukian, PF Caimi Blood 140 (Supplement 1), 8061-8062, 2022 | | 2022 |
